ArticleChinese medicine2021

Efficacy and safety of Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome: study protocol for a multi-center, randomized, double-blind, placebo controlled clinical trial.

Ya Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.